Data / Form D filings / Micron Biomedical, Inc.
Micron Biomedical, Inc.: Form D filings
Micron Biomedical, Inc., a biotechnology company in Atlanta, GA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on December 26, 2024, reports $15 million sold of a $16.2 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 575 Fourteenth Street, NW, Suite 100, Atlanta, GA, 30318
- Phone
- (404) 368-1554
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1957384
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | New notice | $16,249,998 | $14,999,983 | $1,250,015 | 3 | Dec 11, 2024 | sec.gov |
| Apr 17, 2023 | New notice | $2,999,995 | $2,999,995 | 1 | Apr 4, 2023 | sec.gov | |
| Dec 7, 2022 | New notice | $14,014,491 | $14,014,491 | 4 | Nov 22, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Prausnitz | Director | |
| Henry Sebastien | Executive Officer | |
| Devin McAllister | Executive Officer | |
| Idean Marvasty | Executive Officer | |
| Brian Bernick | Director | |
| Bas Van Buijtenen | Director | |
| Steve Damon | Executive Officer, Director | |
| Matthew Goldman | Director | |
| Labeeb Abboud | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Dec 23, 2024 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Micron Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.